The most potent one is indeed efficient in vivo on SCID mice, xenografted with human ABCG2-transfected cells, by chemosensitizing tumor growth to the drug- substrate irinotecan (Honorat, M., et al.Oncotarget 2014, 5, 11957–11970). This evidence concerns the gene ABCG2 and neoplasm.